C07D 285/00
Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only
Official title: Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
C07D285/00 (Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only) appears on 2,860 US grants and 1,954 published applications in this corpus.
Search patents in C07D- Granted patents
- 2,860
- Published applications
- 1,954
- Assignees
- 1,039
- Inventors
- 7,316
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 59 | 0 |
| 1977 | 65 | 0 |
| 1978 | 73 | 0 |
| 1979 | 56 | 0 |
| 1980 | 57 | 0 |
| 1981 | 74 | 0 |
| 1982 | 51 | 0 |
| 1983 | 45 | 0 |
| 1984 | 60 | 0 |
| 1985 | 60 | 0 |
| 1986 | 57 | 0 |
| 1987 | 59 | 0 |
| 1988 | 49 | 0 |
| 1989 | 37 | 0 |
| 1990 | 56 | 0 |
| 1991 | 52 | 0 |
| 1992 | 57 | 0 |
| 1993 | 59 | 0 |
| 1994 | 42 | 0 |
| 1995 | 63 | 0 |
| 1996 | 54 | 0 |
| 1997 | 50 | 0 |
| 1998 | 67 | 0 |
| 1999 | 56 | 0 |
| 2000 | 50 | 0 |
| 2001 | 79 | 14 |
| 2002 | 53 | 53 |
| 2003 | 52 | 73 |
| 2004 | 37 | 98 |
| 2005 | 35 | 98 |
| 2006 | 56 | 91 |
| 2007 | 64 | 80 |
| 2008 | 47 | 117 |
| 2009 | 59 | 79 |
| 2010 | 74 | 146 |
| 2011 | 68 | 90 |
| 2012 | 94 | 82 |
| 2013 | 81 | 81 |
| 2014 | 89 | 108 |
| 2015 | 68 | 76 |
| 2016 | 78 | 71 |
| 2017 | 63 | 82 |
| 2018 | 58 | 78 |
| 2019 | 63 | 54 |
| 2020 | 43 | 68 |
| 2021 | 45 | 67 |
| 2022 | 32 | 47 |
| 2023 | 28 | 54 |
| 2024 | 31 | 68 |
| 2025 | 40 | 48 |
| 2026 | 15 | 31 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents22 Sep 2026US 12,740,943 B2ModernaTX, Inc.
- Thiadiazolone derivatives and their use as AMPK agonists for the treatment of diabetes and related disorders2 Jun 2026US 12,643,918 B2Betagenon AB
- Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof26 May 2026US 12,637,436 B2Sanford Burnham Prebys Medical Discovery Institute
- Compound, display panel and display device26 May 2026US 12,641,998 B2Wuhan Tianma Microelectronics Co., Ltd.
- Amino acid backbone ionizable lipid, preparation method thereof and application method therefor1 Oct 2026US 2026/0294811 A1South China University of Technology
- Bioactive Conjugate, Preparation Method Therefor and Use Thereof17 Sep 2026US 2026/0273080 A2BeOne Medicines I GmbH
- Err modulators17 Sep 2026US 2026/0274807 A1University of Health Sciences & Pharmacy in St. Louis
- N-substituted indazole sulfonamide compounds with selective activity in voltage-gated sodium channels background6 Aug 2026US 2026/0226040 A1Merck Sharp & Dohme Corp.
- Process for preparation of sulfamoyl chloride30 Jul 2026US 2026/0217530 A1Firmenich SA
Most cited
By later US patents
- Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase183US 5,409,944 AMerck Frosst Canada, Inc. · 1995
- Quinoline derivatives as PI3 kinase inhibitors178US 8,138,347 B2GlaxoSmithKline LLC · 2012
- Amide derivatives176US 4,636,505 AImperial Chemical Industries PLC · 1987
- Aryl carbonyl derivatives as therapeutic agents152US 7,384,967 B2Novo Nordisk A/S · 2008
- Analogs of calicheamicin gamma1I, method of making and using the same149US 5,264,586 AThe Scripps Research Institute · 1993